Medical Bulletin 07/October/2023 Isra Zaman7 Oct 2023 3:00 PM ISTHere are the top medical news of the day:GLP-1 Agonists, like Ozempic and Wegovy linked to gastrointestinal risks: studyA recent study presented at a...
Do Fathers suffer from Postpartum Depression? YES, Says New Study Isra Zaman7 Oct 2023 9:30 AM ISTDads can suffer from postpartum depression, and a new pilot study at the University of Illinois Chicago suggests they can and should be screened for...
Esketamine nasal spray shows promise in treatment-resistant depression Isra Zaman7 Oct 2023 9:15 AM ISTIn the realm of treatment-resistant depression, where conventional therapies often fall short, a recent study has shed light on a potential...
Esketamine nasal spray useful option for patients with treatment-resistant depression Dr. Kamal Kant Kohli6 Oct 2023 8:00 PM ISTResearchers have found in a new study that Esketamine Nasal Spray was effective for Treatment-Resistant Depression compared to Quetiapine. The...
Medical Bulletin 04/October/2023 Isra Zaman4 Oct 2023 3:00 PM ISTHere are the top medical news of the day:WHO Recommends new Malaria Vaccine for children which is cost-effective and efficientIn a significant...
Adults shouting at children can be as damaging as sexual or physical abuse: Study Isra Zaman4 Oct 2023 9:00 AM ISTA recent systematic review conducted by researchers at UCL and Wingate University has underscored the need to classify childhood verbal abuse by...
Fatty liver disease patients likely to suffer from personality disorder Dr. Kamal Kant Kohli3 Oct 2023 8:00 PM ISTResearchers also discovered that, whilst NAFLD patients know that they need to watch their diet and exercise to keep the disease in check, they...
Smoking tobacco and cannabis raises risk of depression and anxiety Dr. Kamal Kant Kohli2 Oct 2023 8:00 PM ISTUSA: A recent study published in PLOS One has revealed an association between the co-use of tobacco and cannabis and poor mental...
FDA approves Depression drug after rejecting it multiple times in 20 years Isra Zaman2 Oct 2023 9:15 AM ISTGepirone hydrochloride extended-release (ER), marketed as Exxua, has finally received FDA approval for the treatment of major depressive disorder...
Catheter ablation treatment for AF may improve severe psychological distress Aditi1 Oct 2023 8:00 PM ISTOne-third of patients with Atrial Fibrillation or AF experience severe depression and anxiety. Do these patients benefit from Catheter ablation?In a...
FDA Approves antidepressant Gepirone Hydrochloride to address mood disorders and suicide risk Dr. Kamal Kant Kohli30 Sept 2023 10:00 AM ISTThe US Food and Drug Administration has approved antidepressant Gepirone Hydrochloride to address mood disorders and suicide risk. It is first...
Internet-based therapy may alleviate depression in people with multiple sclerosis: Lancet Dr. Kamal Kant Kohli28 Sept 2023 6:15 PM ISTResearchers have found in a new study that Internet-based therapy may alleviate depression in people with multiple sclerosis. Major depressive...
